Abstract
Alkaptonuria is an iconic disease used by Archibald Garrod to demonstrate the theory of “inborn errors of metabolism”. AKU knowledge has advanced in recent years: development of an in vitro model, discovery of murine models and advances in understanding bone and cartilage phenotypes and arthropathy in AKU. These discoveries have aided in a new clinical trial into nitisinone. However, there are still knowledge gaps surrounding the pigment in AKU and the pigmentation process. We demonstrate an advance in the understanding in the kinetics and chemistry of the polymerisation of homogentisic acid (HGA) into its pigment using size-exclusion chromatography and IR spectroscopy. We compared the properties of HGA-based pigments that were freshly prepared to those stored in solution for 2 years. Our results demonstrate the importance of pH in the polymerisation process and that colour change seen in solution (analogous to AKU patient urine) is not initially due to presence of ochronotic pigment but the quinone intermediary. In addition, we observed that pigment formation from HGA can occur in the presence of tyrosine, without the inclusion of this tyrosine into the pigment. These observations have positive implications for patients with alkaptonuria; an increased understanding of the pigment polymer chemistry, the presence of an intermediary and their kinetics present more therapeutic opportunities for treating the condition, including preventing the pigment from forming, binding or reversing established pigmentation. AKU patients treated with nitisinone show elevated tyrosine levels causing side effects such as corneal opacities; our data demonstrates that elevated tyrosine levels should not contribute or add to the ochronotic pigment burden in these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Apte M, Girme G, Bankar A, RaviKumar A, Zinjarde S (2013) 3, 4-dihydroxy-L-phenylalanine-derived melanin from Yarrowia lipolytica mediates the synthesis of silver and gold nanostructures. J Nanobiotechnol 11:1–9
Chow WY, Taylor AM, Reid DG, Gallagher JA, Duer MJ (2011) Collagen atomic scale molecular disorder in ochronotic cartilage from an alkaptonuria patient, observed by solid state NMR. J Inherit Metab Dis 34:1137–1140
Faccio G, Kruus K, Saloheimo M, Thöny-Meyer L (2012) Bacterial tyrosinases and their applications. Process Biochem 47:1749–1760
Goldfeder M, Egozy M, Shuster Ben-Yosef V, Adir N, Fishman A (2013) Changes in tyrosinase specificity by ionic liquids and sodium dodecyl sulfate. Appl Microbiol Biotechnol 97:1953–1961
Hudson KL, Bartlett GJ, Diehl RC et al (2015) Carbohydrate–aromatic interactions in proteins. J Am Chem Soc 137:15152–15160
Menon IA, Persad SD, Haberman HF et al (1991) Characterization of the pigment from homogentisic acid and urine and tissue from an alkaptonuria patient. Biochem Cell Biol 69:269–273
Mistry JB, Bukhari M, Taylor AM (2013) Alkaptonuria. Rare Dis 1:e27475
Pollak MR, Chou YH, Cerda JJ et al (1993) Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat Genet 5:201–204
Preston AJ, Keenan CM, Sutherland H et al (2014) Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Ann Rheum Dis 73:284–289
Ranganath LR, Milan AM, Hughes AT et al (2016) Suitability of Nitisinone in Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis 75:362–367
Roberts NB, Curtis SA, Milan AM, Ranganath LR (2015) The pigment in alkaptonuria relationship to melanin and other coloured substances: a review of metabolism, composition and chemical analysis. JIMD Rep 24:51–66
Rosa A, Tuberoso CI, Atzeri A, Melis MP, Bifulco E, Dessi MA (2011) Antioxidant profile of strawberry tree honey and its marker homogentisic acid in several models of oxidative stress. Food Chem 129:1045–1053
Sonmez F, Sevmezler S, Atahan A et al (2011) Evaluation of new chalcone derivatives as polyphenol oxidase inhibitors. Bioorg Med Chem Lett 21:7479–7482
Taylor AM, Wilson PJ, Ingrams DR, Helliwell TR, Gallagher JA, Ranganath LR (2010) Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria. J Clin Pathol 63:186–188
Taylor AM, Boyde A, Wilson PJ et al (2011) The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 63:3887–3896
Taylor AM, Preston AJ, Paulk NK et al (2012) Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition. Osteoarthr Cartil 20:880–886
Taylor AM, Kammath V, Bleakley A (2016a) Tyrosinase, could it be a missing link in ochronosis in alkaptonuria? Med Hypotheses 91:77–80
Taylor AM, Hsueh MF, Ranganath LR et al (2016b) Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing. Rheumatology. doi:10.1093/rheumatology/kew355
Tinti L, Taylor AM, Santucci A et al (2011) Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) 50:271–277
Tu YG, Xie MY, Sun YZ, Tian YG (2009) Structural characterization of melanin from Black-bone silky fowl (Gallus gallus domesticus Brisson). Pigm Cell Melanoma Res 22:134–136
Turick CE, Tisa LS, Caccavo F Jr (2002) Melanin production and use as a soluble electron shuttle for Fe(III) oxide reduction and as a terminal electron acceptor by Shewanella algae BrY. Appl Environ Microbiol 68:2436–2444
Zatkova A (2011) An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis 34:1127–1136
Acknowledgements
Dr. Adam Taylor would like to acknowledge the Rosetrees Trust for funding. Dr. Vercruysse was in part supported by the Institute for Food, Agricultural and Environmental Research at Tennessee State University.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Ina Knerr, MD
Electronic Supplementary Material
Fig. 1.
A diagram showing the potential fate of tyrosine through its various pathways (TIFF 24 kb)
Appendices
“Take-Home” Message
Our data shows initial colour change in samples of HGA solution is due to the formation of intermediaries which are not polymerised pigment. C–C and C–O bonds are involved in linking aromatic units in the formation of ochronotic pigment. Tyrosine is not incorporated into ochronotic pigment meaning that patients with elevated plasma tyrosine will not have elevated plasma tyrosine adding or contributing to the pigment burden.
Contribution
Drs. Taylor and Vercruysse have been involved in conception, design, analysis and interpretation of data. Both authors drafted the chapter and revised it critically for important intellectual content.
Rights and permissions
Copyright information
© 2017 Society for the Study of Inborn Errors of Metabolism (SSIEM)
About this chapter
Cite this chapter
Taylor, A.M., Vercruysse, K.P. (2017). Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 35. JIMD Reports, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2016_27
Download citation
DOI: https://doi.org/10.1007/8904_2016_27
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55832-4
Online ISBN: 978-3-662-55833-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)